Medical Device Shortages Demand Greater Supply Chain Resilience

Medical device shortages are putting increased pressure on manufacturers to gain control of their extended supply chains. Supply chain disruptions, several tiers removed from the manufacturer, will quickly ripple through production, negatively impact customer service, and threaten the availability of critical products. To stay ahead of these risks, medical device manufacturers must move beyond reacting to shortages and build resilient supply chains with greater visibility, early warning signals, scenario planning, and advanced technologies that enable rapid, proactive decision-making.

Medical Device Shortages Highlight Supply Chain Vulnerabilities

Medical device shortages continue to expose vulnerabilities buried deep within global supply chains. According to the U.S. Food and Drug Administration’s (FDA) June 2026 Medical Device Shortages List, shortages are affecting many products including neurosurgical patties, stereotactic breast biopsy needles, angiographic control syringes, endoscopic vessel harvesting systems, and oxygenator devices used for extracorporeal circulation. Several of these shortages are expected to continue into 2027. These scarcities were caused by down-the-line shortages with tier 2 and 3 suppliers in the end-to-end supply chain. 

Other causes could include manufacturing and quality problems, geopolitical issues, natural disasters, delays, public health emergencies, and product discontinuations. Tariffs, changing trade relationships, transportation disruptions, and competition for critical materials add further complexity. Thus, manufacturers must understand not only their immediate suppliers but their extended end-to-end supply chains if they want to succeed.

FDA Prioritizes Supply Chain Resilience

As these types of issues continue to increase, the need for resiliency has gained momentum. The FDA has elevated the importance of supply continuity through its Office of Supply Chain Resilience (OSCR), which focuses on strengthening medical device value chains by proactively monitoring, assessing, and communicating risks and vulnerabilities. Rather than focusing solely on shortages after they occur, OSCR’s objective is to prevent and mitigate supply chain disruptions. The office performs shortage assessments, collaborates with manufacturers, healthcare organizations, and government partners, and uses advanced analytics, technologies, and modeling to proactively monitor supply chain risks.

Proactive medical device manufacturers are taking a similar approach. Instead of lacking visibility beyond their immediate suppliers, they are putting processes in place to identify critical suppliers and components, understand where sole-source and geographic dependencies exist, assess capacity and lead-time risks, and develop early warning signals before disruptions turn into shortages. These strategies are no longer optional for companies that want to stay in business for the long term.

From product launches to M&A and manufacturing trends, the MPO Source delivers the medtech news you need twice a week. Subscribe here!

Visibility and Scenario Planning Provide Early Warning Signals

Visibility is the foundation of a resilient supply chain, but simply collecting more data will not solve the problem. Manufacturers must connect demand, supply, inventory, production capacity, suppliers, and customer requirements so they can determine the impact of changing conditions and take action. With the right visibility and early warning signals, manufacturers can identify potential shortages and constraints before they disrupt production and customer service.

For example, a medical device manufacturer struggled to meet customer requirements when shortages originating with tier 2 and 3 suppliers disrupted the flow of critical materials and components. The company lacked visibility into its extended supply chain, and its ERP and planning tools were not being fully utilized to provide the early warning signals needed to anticipate these issues. Therefore, the manufacturer assessed the situation to determine how to change the circumstances and ensure a sustainable solution was rolled out. 

The assessment evaluated the end-to-end supply chain to identify visibility gaps, potential vulnerabilities, and the early warning signals needed to proactively address disruptions. Scenario analyses were conducted to determine how supplier constraints would affect production and customer requirements. Recommendations were developed to adjust production schedules and purchase plans across the company’s facilities, outsourced suppliers, and extended supply chain to best support customer needs at the lowest cost. 

Simple early warning signals were implemented with key suppliers and/or at critical points in the process. For example, as the supplier’s raw material availability flipped to green, it triggered communication upstream. Similarly, if there was a missed receipt that created a potential reschedule, alerts were sent. This type of event was put in place at critical junctures such as production, shipment, and port entry so the manufacturer could adjust accordingly. 

Advanced Technologies Enable Sustainable Solutions

To ensure a sustainable solution, the manufacturer upgraded its use of demand planning, advanced planning and scheduling (APS), master production scheduling (MPS), and material requirements planning (MRP). Instead of reacting to a missed supplier commitment, the company simply connected changing demand with material requirements, production capacity, supplier commitments, and inventory availability.

This improved visibility provided earlier warning signals so that executives and planners could proactively address exceptions. If a critical component was going to constrain production, they could determine which products and customers would be affected, evaluate alternate production and sourcing scenarios, adjust purchase plans, and prioritize available capacity and materials before customer service deteriorated.

Technology didn’t eliminate supply chain risk; rather, it provided the information and time required to manage it. Scenario planning turns that visibility into action. What happens if a critical supplier loses capacity? What if a tier 3 component becomes unavailable? What if lead times double, tariffs increase costs, or demand changes unexpectedly?

Advanced planning systems combined with SIOP (Sales Inventory and Operations Planning) processes allow executives to evaluate these alternatives across the end-to-end supply chain and determine the impact on service, cost, inventory, capacity, and risk. Instead of scrambling when a shortage occurs, manufacturers can develop options in advance and respond rapidly as conditions change.

Building a Resilient Medical Device Supply Chain

Medical device manufacturers should prioritize the components and suppliers that create the greatest risk to production and customer service. Not every component requires the same level of attention. Critical, sole-source, long lead-time, highly regulated, or difficult-to-replace components warrant greater visibility and contingency planning.

There is no time to delay. Start by mapping critical suppliers beyond tier 1 wherever practical. Determine which suppliers, manufacturing locations, materials, tooling, and transportation lanes could create a single point of failure. Assess supplier capacity, identify geographic concentrations, evaluate alternate sources, and determine how long it will take to qualify a replacement.

Qualified replacements are not easy to develop. Since manufacturers must consider quality requirements, validation, engineering specifications, regulatory considerations, tooling, and available capacity, it can take a significant period to shift supply. Thus, manufacturers must work collaboratively with critical suppliers and partners before a disruption occurs because once an interruption occurs, it is too late. On the other hand, the prepared will thrive.

The most proactive companies develop inventory strategies that reflect risk. Lean inventory will suffice for predictable, readily available components, but minimizing inventory for components that can shut down production is unacceptable. As a part of a well-functioning SIOP process, inventory decisions will account for lead times, supplier reliability, qualification requirements, capacity, customer impact, and recovery time.

Finally, utilize ERP, demand planning, APS, MPS, MRP, SIOP, AI, and advanced analytics to connect demand with supply and provide early warning signals. The objective isn’t more technology. It is to identify exceptions earlier, evaluate alternatives rapidly, and make better decisions before a potential disruption becomes a customer shortage.

The Bottom Line

Medical device shortages demonstrate that supply chain vulnerabilities can originate far beyond a manufacturer’s four walls. The FDA’s focus on supply chain resilience reinforces the importance of moving from reactive shortage management to proactive risk identification and mitigation. The best medtech manufacturers are taking the same approach.

Companies must gain visibility into their extended supply chains, fully utilize ERP and advanced planning capabilities, develop meaningful early warning signals, and routinely evaluate scenarios. The goal isn’t to predict every disruption. It is to identify vulnerabilities early enough to have options and to respond quickly enough to protect customers, profitability, and growth.

More from this author: AI and Hyperscale Manufacturing Fuels Profitable Growth

Lisa Anderson is founder and president of LMA Consulting Group Inc., a consulting firm specializing in manufacturing strategy and end-to-end supply chain transformation that maximizes the customer experience and enables profitable, scalable, dramatic business growth. She recently released “SIOP (Sales Inventory and Operations Planning): Creating Predictable Revenue and EBITDA Growth,” an e-book on how to better navigate supply chain chaos and ensure profitable, scalable business growth. A complimentary download can be found at www.lma-consultinggroup.com/siop-book.